A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin Lymphoma
Condition: B-Cell Non-Hodgkin Lymphoma Interventions: Drug: Epcoritamab; Drug: Cyclophosphamide; Drug: Rituximab; Drug: Doxorubicin; Drug: Vincristine; Drug: Prednisone; Drug: Lenalidomide Sponsors: AbbVie; Genmab Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 21, 2022 Category: Research Source Type: clinical trials
Fitness Assessment in Young Adults Recovered From Lymphoma
Conditions: Young Adults; Lymphoma, Non-Hodgkin; Hodgkin Disease Intervention: Other: Indirect calorimetric test during submaximal exercise Sponsor: University Hospital, Clermont-Ferrand Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2022 Category: Research Source Type: clinical trials